GBM CSCs-IN-2
GBM CSCs-IN-2 is a GBM CSCs growth inhibitor with blood-brain barrier penetration capability. GBM CSCs-IN-2 activates ASIC3 through an ASIC3 binding pocket that overlaps with GMQ, chronically activating this proton-gated Na+ channel, thereby inhibiting cancer stem cell growth without reducing the viability of cells lacking ASIC3. GBM CSCs-IN-2 can be used in research related to glioblastoma.
For research use only. We do not sell to patients.
- Formula: C11H13ClN6
- Molecular Weight:264.71
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MES-0315 GBM CSCs
-
Concentration:10 µM
-
Incubation Time:72 h
-
Result:MES-0315 GBM CSC 3D neurosphere growth was inhibited by 42.4% at 10 µM.
Parmacokinetics
| Species | Dose | Route | B/P |
|---|---|---|---|
| Mice[1] | 2 mg/kg | i.v. | 25.4 % |
Chemical Information
-
Molecular Weight 264.71
-
Formula C11H13ClN6
-
SMILES
NC(N/N=C/C1=NC2=CC=CC=C2C(C)=N1)=N.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)